3
Announcements
Trials
Browse
Landscape
Phase
Phase NA
1
Status
Completed
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Gynecologic
1
Gastrointestinal
1
Breast
1
Conditions
Breast Neoplasms
27
Neoplasms
25
Lung Neoplasms
12
Uterine Cervical Neoplasms
11
Colorectal Neoplasms
10
Colonic Neoplasms
8
Motor Activity
7
Urinary Bladder Neoplasms
6
Rectal Neoplasms
6
Vulvar Neoplasms
5
Obesity
5
Endometrial Neoplasms
5
Carcinoma, Non-Small-Cell Lung
5
Melanoma
4
Head and Neck Neoplasms
4
Anxiety Disorders
4
Stomach Neoplasms
3
Sarcoma
3
Prostatic Neoplasms
3
Papillomavirus Infections
3
Lymphoma
3
Hematopoietic and Lymphoid System Neoplasm
3
Hematologic Neoplasms
3
Depression
3
Carcinoma, Ovarian Epithelial
3
Breast Carcinoma In Situ
3
Vaginal Neoplasms
2
Testicular Neoplasms
2
Smoking Cessation
2
Skin Neoplasms
2
Interventions
Surveys and Questionnaires
5
Pemetrexed
3
Paclitaxel
3
Gemcitabine
3
Docetaxel
3
Brachytherapy
3
pembrolizumab
2
Topotecan
2
Saline Solution
2
Radiotherapy
2
Radiation
2
FANG vaccine
2
Everolimus
2
Doxorubicin
2
Cisplatin
2
Carboplatin
2
CP protocol
2
temsirolimus
1
selinexor
1
osimertinib
1
niraparib
1
fosaprepitant
1
ferumoxtran-10
1
ferrous fumarate
1
durvalumab
1
cobimetinib
1
atezolizumab
1
alovudine
1
Vitamin D
1
Uterine Artery Embolization
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Completed
×
Uterine Neoplasms
×
Methods
×
Clear all
NCT05939440
2025-06-05
P-COC
University of Alabama at Birmingham
Phase NA
Completed
60 enrolled